A versatile nanoplatform for synergistic combination therapy to treat human esophageal cancer-Reference-Cited by-同舟云学术

A versatile nanoplatform for synergistic combination therapy to treat human esophageal cancer

Published:2017-05-29 Issue:6 Volume:38 Page:931-942
ISSN:1671-4083
Container-title:Acta Pharmacologica Sinica
language:en
Short-container-title:Acta Pharmacol Sin

Author:

Wang Xin-shuai,Kong De-jiu,Lin Tzu-yin,Li Xiao-cen,Izumiya Yoshihiro,Ding Xue-zhen,Zhang Li,Hu Xiao-chen,Yang Jun-qiang,Gao She-gan,Lam Kit S,Li Yuan-pei

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://www.nature.com/articles/aps201743.pdf

Reference48 articles.

1. Siegel RL, Miller KD, Jemal A . Cancer statistics, 2016. CA Cancer J Clin 2016; 66: 7–30.

2. Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. CA Cancer J Clin 2016; 66: 115–32.

3. Collins DC, Sundar R, Lim JS, Yap TA . Towards precision medicine in the clinic: From biomarker discovery to novel therapeutics. Trends Pharmacol Sci 2017; 38: 25–40.

4. Tan Q, Liu X, Fu X, Li Q, Dou J, Zhai G . Current development in nanoformulations of docetaxel. Expert Opin Drug Deliv 2012; 9: 975–90.

5. Fushida S, Nashimoto A, Fukushima N, Kawachi Y, Fujimura T, Kuwabara S, et al. Phase II trial of preoperative chemotherapy with docetaxel, cisplatin and S-1 for T4 locally advanced gastric cancer. Jpn J Clin Oncol 2012; 42: 131–3.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application and development of nanomaterials in the diagnosis and treatment of esophageal cancer;Frontiers in Bioengineering and Biotechnology;2023-11-03

2. Nanotechnology-based combinatorial phototherapy for enhanced cancer treatment;RSC Advances;2022

3. Thiophene donor for NIR-II fluorescence imaging-guided photothermal/photodynamic/chemo combination therapy;Acta Biomaterialia;2021-06

4. Polymeric Nanoparticles and Their Novel Modifications for Targeted Delivery of Bortezomib;Pharmaceutical Sciences;2020-12-25

5. Folate-Targeted Cholesterol-Grafted Lipo-Polymeric Nanoparticles for Chemotherapeutic Agent Delivery;AAPS PharmSciTech;2020-10